- Home
- MTEN vs IXHL Comparison
MTEN vs IXHL Comparison
Compare MTEN & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- IXHL
- Stock Information
- Founded
- MTEN 2015
- IXHL 2001
- Country
- MTEN China
- IXHL Australia
- Employees
- MTEN N/A
- IXHL N/A
- Industry
- MTEN Building Products
- IXHL
- Sector
- MTEN Industrials
- IXHL
- Exchange
- MTEN Nasdaq
- IXHL Nasdaq
- Market Cap
- MTEN 36.6M
- IXHL 39.2M
- IPO Year
- MTEN 2024
- IXHL N/A
- Fundamental
- Price
- MTEN $6.25
- IXHL $1.89
- Analyst Decision
- MTEN
- IXHL
- Analyst Count
- MTEN 0
- IXHL 0
- Target Price
- MTEN N/A
- IXHL N/A
- AVG Volume (30 Days)
- MTEN 39.1K
- IXHL 24.1K
- Earning Date
- MTEN 10-18-2024
- IXHL 11-14-2024
- Dividend Yield
- MTEN N/A
- IXHL N/A
- EPS Growth
- MTEN N/A
- IXHL N/A
- EPS
- MTEN 0.13
- IXHL N/A
- Revenue
- MTEN $9,136,855.00
- IXHL $86,000.00
- Revenue This Year
- MTEN N/A
- IXHL $3,817.06
- Revenue Next Year
- MTEN N/A
- IXHL $66.67
- P/E Ratio
- MTEN $47.28
- IXHL N/A
- Revenue Growth
- MTEN 18.30
- IXHL N/A
- 52 Week Low
- MTEN $1.81
- IXHL $1.50
- 52 Week High
- MTEN $9.87
- IXHL $8.47
- Technical
- Relative Strength Index (RSI)
- MTEN N/A
- IXHL 49.91
- Support Level
- MTEN N/A
- IXHL $1.71
- Resistance Level
- MTEN N/A
- IXHL $1.95
- Average True Range (ATR)
- MTEN 0.00
- IXHL 0.13
- MACD
- MTEN 0.00
- IXHL 0.00
- Stochastic Oscillator
- MTEN 0.00
- IXHL 32.77
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.